Bellevue Life Sciences Acquisition Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Peter Hwang
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.2yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO
Peter Hwang (47 yo)
4.2yrs
Tenure
Mr. Kuk Hyoun Hwang, also known as Peter, is Chief Executive Officer & Director of Bellevue Life Sciences Acquisition Corp. since March 2020. Mr. Hwang is the Managing Partner of BCM, which he founded in A...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 4.2yrs | no data | no data | |
Independent Chairman of the Board | 1.3yrs | no data | 0.36% $ 214.6k | |
Independent Director | 1.3yrs | no data | 0.36% $ 214.6k | |
Director | 3.8yrs | no data | no data | |
Independent Director | 1.3yrs | no data | 0.36% $ 214.6k | |
Independent Director | 1.3yrs | no data | 0.36% $ 214.6k |
1.3yrs
Average Tenure
56.5yo
Average Age
Experienced Board: BLAC's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.